Search

1. Foster care: HHS has taken steps to support states' oversight of psychotropic medications, but additional assistance could further collaboration : report to Congressional requesters

Publication:

Washington, D.C. : U.S. Government Accountability Office, January 2017

Subject(s):

Child Welfare
Drug Utilization -- statistics & numerical data
Foster Home Care
Inappropriate Prescribing -- prevention & control
Psychotropic Drugs -- therapeutic use
United States
United States. Department of Health and Human Services

2. Trends in opioid use among social security disability insurance applicants

Author(s):

Wu, April Yanyuan, author
Brandt, Denise Hoffman, author
O'Leary, Paul, author

Publication:

Chestnut Hill, MA : Center for Retirement Research at Boston College, March 2021

Subject(s):

Analgesics, Opioid -- therapeutic use
Persons with Disabilities -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Insurance, Disability -- statistics & numerical data
Insurance, Disability -- trends
Social Security -- statistics & numerical data
Social Security -- trends
United States

3. Medicare Part B drugs: trends in spending and utilization, 2008-2021

Author(s):

Nguyen, Nuguyen X., author
Olsen, T. Anders, author
Sheingold, Steven, author
De Lew, Nancy, author

Publication:

Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, June 9, 2023

Subject(s):

Cost Control
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Medicare Part B -- economics
United States
United States.

4. COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 2022

Author(s):

Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022

Subject(s):

Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States

5. Early changes in waivered clinicians and utilization of buprenorphine for opioid use disorder after implementation of the 2021 HHS Buprenorphine Practice Guidelines

Publication:

Washington, D.C. : U.S. Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 2, 2022

Subject(s):

Buprenorphine -- therapeutic use
Drug Prescriptions -- statistics & numerical data
Drug Utilization -- statistics & numerical data
Drug Utilization -- trends
Opioid-Related Disorders -- drug therapy
Practice Guidelines as Topic
Scope of Practice
United States
United States. Department of Health and Human Services